2602 Pazopanib (Pz) as first line for metastatic renal carcinoma (mRC): Updated validation of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model (IMRCC). The SPAZO study (SOGUG). (September 2015)

• Record Type: Journal Article
• Authors: Perez-Valderrama, B.; Arija, J.A. Arranz; Vidal, M.J. Méndez; Carbonero, I. García; Rodríguez, C. Suárez; Gallego, P. Jiménez; López-Brea, M.; Marrero, R.D. García; García, J.A. Meana; Gajate, P.; Santander, C.; Palau, C. Molins; Parra, E.M. Fernández; Torras, O. Reig; Basterrechea, L.; Estévez, S. Vázquez; Borrega, P.; Sánchez, A. Rodríguez; Pinto, A.; Castellano, D.E.
• Is Part Of: European journal of cancer. Volume 51:(2015)Supplement 3
• Page Start: S512
• Publication Date: 2015-09
• Subjects: Cancer -- Periodicals; Neoplasms -- Periodicals; Cancer -- Périodiques; Cancer; Tumors; Electronic journals; Periodicals; Electronic journals; 616.994
• DOI: 10.1016/S0959-8049(16)31420-4
• Languages: English
• ISSNs: 0959-8049